Friday, November 06, 2020 6:27:09 AM
Agreed. If we go by the company given estimated time for each step, they are probably now into the second week of possession of TLD and in discussions with various committees and experts. ( I’ve given the stat people 3 weeks for cushion). They are now in control of when to publicly announce the results. If we go with Flipper’s take that detailed results will be presented at ESMO, it should not preclude them from announcing the barest key metrics of the results prior to the conference. So if they require the full three weeks of consultation in crafting the public release of TLD, this should take us into the 3rd week of November latest and plenty of time to do the number crunching for the last 5 years patients if they have enough alpha as proposed by Flipper . In between there is only a two week or so to ESMO.
In the end the company will do what it wants to do at their own internal timeline and objectives. We are all speculating on thin air to amuse ourselves while twiddling our thumbs while we wait. I’m not going to get all worked up now nor go on a ramen diet to buy more shares.
In the end the company will do what it wants to do at their own internal timeline and objectives. We are all speculating on thin air to amuse ourselves while twiddling our thumbs while we wait. I’m not going to get all worked up now nor go on a ramen diet to buy more shares.
Pedal to the metal
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
